What does Novartis India do?

Jul 17 2025 06:59 AM IST
share
Share Via
Novartis India Ltd, a subsidiary of Swiss pharmaceutical company Novartis, manufactures and markets drugs in the Pharmaceuticals & Biotechnology sector. As of March 2025, it reported net sales of ₹839 Cr and a net profit of ₹293 Cr, with a market cap of ₹2,617 Cr.
Overview:
Novartis India Ltd is a subsidiary of the Swiss pharmaceutical giant Novartis, engaged in the manufacturing and marketing of drugs and pharmaceutical products within the Pharmaceuticals & Biotechnology industry, categorized as a Small Cap company.

History:
Incorporated on 13 December 1947, Novartis India Ltd has maintained its status as a subsidiary of Novartis. The latest quarterly results reported net sales and net profit for the period ending March 2025.

Financial Snapshot:
Most recent Net Sales: 839 Cr (Quarterly Results - Mar 2025)
Most recent Net Profit: 293 Cr (Quarterly Results - Mar 2025)
Market-cap value: INR 2,617 Cr (Small Cap)

Key Metrics:
P/E: 26.00
Industry P/E: 37
Dividend Yield: 2.37%
Debt-Equity: -0.83
Return on Equity: 12.85%
Price to Book: 3.32

Contact Details:
Address: The Inspire BKC Part 601 & 701, Bandra Kurla Complex Bandra(E) Mumbai Maharashtra : 400051
Phone: 91-022-50243000
Email: india.investors@novartis.com
Website: http://www.novartis.in
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Novartis India falling/rising?
Dec 05 2025 12:56 AM IST
share
Share Via
Why is Novartis India falling/rising?
Nov 06 2025 10:05 PM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 05 2025 08:06 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 03 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 02 2025 08:04 AM IST
share
Share Via
Is Novartis India overvalued or undervalued?
Nov 01 2025 08:05 AM IST
share
Share Via